Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing.
about
Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivoWX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects.Drug Repositioning for Effective Prostate Cancer Treatment.Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines.
P2860
Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical pharmacodynamic ev ...... r anticancer drug repurposing.
@en
type
label
Preclinical pharmacodynamic ev ...... r anticancer drug repurposing.
@en
prefLabel
Preclinical pharmacodynamic ev ...... r anticancer drug repurposing.
@en
P2093
P2860
P356
P1433
P1476
Preclinical pharmacodynamic ev ...... r anticancer drug repurposing.
@en
P2093
Dexuan Yang
Shanshan Wang
Shoujun Yuan
P2860
P304
P356
10.3892/OL.2016.4380
P577
2016-03-29T00:00:00Z